Abstract: Methods of detecting platinum and copper in a test sample are provided. Kits for use in detecting platinum and copper in a test sample also are provided.

Abstract: The present disclosure relates to acid-blocked alkylaminopyridine catalysts for use in a polyurethane formulation. The polyurethane formulation may include the acid-blocked alkylaminopyridine catalyst, a compound containing an isocyanate functional group, an active hydrogen-containing compound and a halogenated olefin compound.

Abstract: The present disclosure relates to acid-blocked pyrrolidine catalysts for use in a polyurethane formulation. The polyurethane formulation includes the acid-blocked pyrrolidine catalyst, a compound containing an isocyanate functional group, an active hydrogen-containing compound and a halogenated olefin compound. The use of such acid-blocked pyrrolidine catalysts show surprisingly low reactivity with halogenated olefin compounds yet sufficient reactivity to catalyze polyurethane formation.

Abstract: The present disclosure relates to a polyol resin blend for use in a polyurethane formulation. The polyol resin blend generally includes (a) an amine having a pKa value between about 6 and about 8.5 and a protonated amine obtained by contacting a methylamino-containing tertiary amine or primary etheramine having a pKa value greater than about 9 and an acid compound, (b) a polyol, and (c) a halogenated olefin. The present disclosure also provides polyurethane formulations containing the polyol resin blend and methods of making polyurethane foam from such polyurethane formulations.

Abstract: Methods of detecting platinum and copper in a test sample are provided. Kits for use in detecting platinum and copper in a test sample also are provided.

Abstract: Methods of detecting platinum and copper in a test sample are provided. Kits for use in detecting platinum and copper in a test sample also are provided.

Abstract: Provided herein are compounds useful in treating exposure to an organophosphorus compound, such as a nerve agent, pesticide, or, generally, an acetylcholinesterase inhibitor, such as sarin. Compositions, e.g. pharmaceutical compositions or dosage forms, comprising the compounds also are provided herein. Methods of treating a patient exposed to a nerve agent, pesticide, or, generally, an acetylcholinesterase inhibitor, e.g., an organophosphorus compound, such as sarin, also are provided.

Abstract: Methods of detecting platinum and copper in a test sample are provided. Kits for use in detecting platinum and copper in a test sample also are provided.